Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03702322 · ClinicalTrials.gov registry record · NA
Improving Voice Production for Adults With Age-related Dysphonia
A NA study of Presbylarynx and Age-Related Dysphonia, sponsored by University of Arizona.
- Active
- Registry status
- NA
- Development phase
- 220
- Enrollment target
- 2
- Study locations
NCT03702322 is a NA study of Presbylarynx and Age-Related Dysphonia that is active but no longer recruiting, run by University of Arizona. The registered enrollment target is 220 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT03702322, a NA study of Presbylarynx and Age-Related Dysphonia, is active but no longer recruiting, sponsored by University of Arizona.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objectives for this research are to determine the mechanisms by which specific therapy tasks improve voice in age-related dysphonia, and the conditions that limit the extent of improvement. The central hypothesis is that targeted therapy tasks will improve voice, and that severity will determine the extent of improvement.
Conditions Studied
Interventions
- BEHAVIORAL Voice therapy: respiratory
- BEHAVIORAL Voice therapy: glottal closure
- BEHAVIORAL Voice therapy: loud
- BEHAVIORAL Voice therapy: Semiocclusion
Study Locations (2)
Arizona
- Mayo Clinic - Scottsdale
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03702322
The ClinicalTrials.gov registry entry for NCT03702322 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Presbylarynx appearing as the primary indexed condition, and to 4 interventions - of which Voice therapy: respiratory is the first listed.
NCT03702322 reports 2 study locations spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT03702322 about?
NCT03702322 is a clinical study titled "Improving Voice Production for Adults With Age-related Dysphonia". The objectives for this research are to determine the mechanisms by which specific therapy tasks improve voice in age-related dysphonia, and the conditions that limit the extent of improvement. The central hypothesis is that targeted therapy tasks will improve voice, and that severity will determine...
What is the current status of trial NCT03702322?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2019-04-01. Estimated completion is 2026-12-30.
What conditions does trial NCT03702322 study?
This clinical trial studies the following conditions: Presbylarynx, Age-Related Dysphonia.
What interventions are being tested in trial NCT03702322?
The interventions under investigation include: Voice therapy: respiratory (BEHAVIORAL), Voice therapy: glottal closure (BEHAVIORAL), Voice therapy: loud (BEHAVIORAL), Voice therapy: Semiocclusion (BEHAVIORAL).
Who is sponsoring clinical trial NCT03702322?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03702322 being conducted?
This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbylarynx
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.